CTLA4 and hypophysitis: Previous reports indicate that the duration before the onset of hypophysitis and thyrotoxicosis caused by a combination of anti-PD-1 and anti-CTLA-4 antibodies differs, averaging 10.3 weeks and two weeks after the first administration, respectively [4-6].